What are the treatment options for a pregnant patient with melasma (Chloasma)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Melasma (Chloasma) During Pregnancy

The primary management of melasma during pregnancy is strict photoprotection with broad-spectrum sunscreen (SPF 50+ with high UVA protection) starting from the first trimester, as active treatment with depigmenting agents should be avoided until after delivery.

Photoprotection: The Cornerstone of Management

Rigorous sun protection is the only evidence-based intervention safe and effective during pregnancy 1, 2:

  • Apply broad-spectrum sunscreen daily with SPF 50+ and UVA-PF ≥28 starting in the first trimester 1
  • Physical blockers (titanium dioxide, zinc oxide) are preferred over chemical blockers due to broader protection and minimal systemic absorption 3
  • Reapply sunscreen every 2 hours during sun exposure 1
  • Use additional physical barriers: wide-brimmed hats, protective clothing, and seek shade 3, 4
  • Avoid peak sun hours (10 AM to 4 PM) 2

Clinical evidence demonstrates that proper photoprotection reduces melasma incidence from 53% to 2.7% in pregnant women 1. In one controlled trial, only 5 out of 185 pregnant women using broad-spectrum sunscreen developed new melasma, compared to historical rates exceeding 50% 1.

What NOT to Use During Pregnancy

Hydroquinone is contraindicated during pregnancy 5:

  • Hydroquinone is Pregnancy Category C with unknown fetal harm potential 5
  • Animal reproduction studies have not been conducted with topical hydroquinone 5
  • Despite being the mainstay treatment for melasma outside pregnancy, it should NOT be used until after delivery 3

Avoid all systemic and most topical depigmenting agents during pregnancy 3:

  • Tretinoin and other retinoids are teratogenic 6
  • Medium-depth chemical peels carry unpredictable results and potential adverse effects 3
  • Laser treatments should be deferred until postpartum 3

Safe Topical Options (Limited Evidence)

Azelaic acid 20% may be considered if treatment is deemed absolutely necessary 6, 7:

  • Pregnancy Category B with no teratogenic effects observed in animal studies 7
  • Provides comedolytic, antibacterial, and anti-inflammatory effects 6
  • Particularly beneficial for darker skin types due to lightening effect on post-inflammatory hyperpigmentation 6
  • However, embryotoxic effects were observed in animals at very high oral doses (2500 mg/kg/day in rats) within toxic dose ranges 7
  • Should only be used if clearly needed, as there are no adequate well-controlled studies in pregnant women 7

Vitamin D Supplementation

Oral vitamin D supplementation should be recommended to prevent deficiency while avoiding UV exposure 4:

  • Strict photoprotection can lead to vitamin D deficiency 4
  • Supplementation allows continued sun avoidance without nutritional consequences 4

Patient Counseling and Expectations

Educate patients that melasma during pregnancy is self-limited but requires patience 3, 2:

  • Spontaneous resolution typically occurs postpartum but may take months 3
  • Up to 30% of cases persist after delivery, even up to 10 years later 2
  • Recurrence and aggravation are common in subsequent pregnancies 2
  • Prevention through photoprotection is far more effective than treatment 1, 2

Risk Factors to Discuss

Identify patients at higher risk who need more aggressive photoprotection 8:

  • Skin types I-II (lighter skin) show significantly better response to photoprotection 8
  • History of melasma in previous pregnancies increases recurrence risk 2
  • Use of cosmetics may influence melasma development 8
  • UV-B, UV-A, and visible light all stimulate melanogenesis 3

Common Pitfalls to Avoid

  • Do NOT prescribe hydroquinone during pregnancy, even though it is the standard treatment outside pregnancy—wait until postpartum 5, 3
  • Do NOT delay photoprotection until melasma appears—start broad-spectrum sunscreen from the first trimester for prevention 1, 2
  • Do NOT use destructive modalities (cryotherapy, medium-depth peels, lasers) during pregnancy due to unpredictable results and potential adverse effects 3
  • Do NOT reassure patients that all melasma resolves quickly postpartum—up to 30% of cases persist long-term, so prevention is critical 2
  • Do NOT forget vitamin D supplementation when recommending strict sun avoidance 4

Postpartum Treatment Planning

Defer active treatment with depigmenting agents until after delivery and lactation 5, 3:

  • Hydroquinone can be initiated postpartum but exercise caution during breastfeeding 5
  • Topical tretinoin and combination therapies become options after pregnancy 3
  • Laser and procedural treatments can be considered postpartum 3

References

Research

Evaluation of the effectiveness of a broad-spectrum sunscreen in the prevention of chloasma in pregnant women.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2007

Research

Prevention of Melasma During Pregnancy: Risk Factors and Photoprotection-Focused Strategies.

Clinical, cosmetic and investigational dermatology, 2024

Research

Chloasma--the mask of pregnancy.

Collegium antropologicum, 2008

Research

[Melasma : An update on the clinical picture, treatment, and prevention].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2017

Guideline

Management of PCOS-Related Acne in Early Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.